GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (LSE:TCF) » Definitions » Total Receivables

TheraCryf (LSE:TCF) Total Receivables : £0.41 Mil (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is TheraCryf Total Receivables?

TheraCryf's Total Receivables for the quarter that ended in Sep. 2024 was £0.41 Mil.


TheraCryf Total Receivables Historical Data

The historical data trend for TheraCryf's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TheraCryf Total Receivables Chart

TheraCryf Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.02 0.01 0.04 0.50

TheraCryf Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.04 0.58 0.50 0.41

TheraCryf Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


TheraCryf Total Receivables Related Terms

Thank you for viewing the detailed overview of TheraCryf's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


TheraCryf Business Description

Traded in Other Exchanges
N/A
Address
Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
TheraCryf PLC is a clinical-stage biotechnology company focused on profitable segments in oncology and neuropsychiatry. The company's lead clinical asset, SFX-01 is a patented form of delivering sulforaphane, which could be used in the treatment of a number of cancers, neurodevelopmental disorders, and other diseases.

TheraCryf Headlines

From GuruFocus

Tcf Financial Corp (TCF) EVP, CFO Brian W Maass Sold $500,259 of Shares

By GuruFocus Research GuruFocus Editor 02-23-2021

Tcf Financial Corp (TCF) EVP, CFO Brian W Maass Sold $1.1 million of Shares

By GuruFocus Research GuruFocus Editor 03-12-2021

Tcf Financial Corp (TCF) EVP, CFO Brian W Maass Sold $887,338 of Shares

By GuruFocus Research GuruFocus Editor 02-05-2021

Lindsay Yousif Named TCF Bank's Chief Compliance Officer

By Business Wire Business Wire 11-19-2020

TCF Declares Quarterly Cash Dividends

By Business Wire Business Wire 01-27-2021

New TCF Banking Center Opens on West Seven Mile in Detroit

By Business Wire Business Wire 02-26-2021

TCF National Bank Acquires BB&T Commercial Equipment Capital, Corp.

By Business Wire Business Wire 02-01-2021